Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, Takuro, Nishikawa, Hiroyoshi, Wada, Hisashi, Nagano, Yuji, Sugiyama, Daisuke, Atarashi, Koji, Maeda, Yuka, Hamaguchi, Masahide +14 more·2016·Nature Medicine

DOI 10.1038/nm.4086

Cited by (874)

Items 101–200 of 874

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
Azharuddin Sajid Syed Khaja, Salman M. Toor, Haytham El Salhat, Issam Faour, Navid Ul Haq, Bassam R. Ali, Eyad Elkord · 2017 · Oncotarget
Triple negative breast cancer – prognostic role of immune-related factors: a systematic review
Elisabeth Specht Stovgaard, Dorte Lisbet Nielsen, Estrid Vilma Solyom Høgdall, Eva Balslev · 2017 · Acta Oncologica
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
Taichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, Shin Yoshida, Shinobu Tomochika, Yuki Nakagami, Hiroto Matsui, Yoshitaro Shindo, Shinsuke Kanekiyo, Yukio Tokumitsu et al. · 2019 · British Journal of Cancer
Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
Shinji Matsutani, Masatsune Shibutani, Kiyoshi Maeda, Hisashi Nagahara, Tatsunari Fukuoka, Shigetomi Nakao, Kosei Hirakawa, Masaichi Ohira · 2018 · Cancer Science
Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer
Lulu Sun, Yi Zhang, Jie Cai, Bipin Rimal, Edson R. Rocha, James P. Coleman, Chenran Zhang, Robert G. Nichols, Yuhong Luo, Bora Kim et al. · 2023 · Nature Communications
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
Sally Naji Temraz, Farah J. Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali I. Shamseddine · 2019 · International Journal of Molecular Sciences
Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Justine Cinier, Margaux Hubert, Laurie Besson, Anthony Di Roio, Céline Rodriguez, Vincent Lombardi, Christophe Caux, Christine Ménétrier‐Caux · 2021 · Cancers
Diet, lipids, and antitumor immunity
Hannah Prendeville, Lydia Lynch · 2022 · Cellular and Molecular Immunology
Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis
Kumar, Prabhakaran, Saini, Shikha, Prabhakar, Bellur S. · 2020 · Seminars in Cancer Biology
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies
Massimo Claudio Fantini, Ilaria Guadagni · 2021 · Digestive and Liver Disease
Regulatory T cells in the tumour microenvironment
Charlotte J. Imianowski, Qiang Chen, Creg J. Workman, Dario A.A. Vignali · 2025 · Nature reviews. Cancer
Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity
Yano, Hiroshi, Andrews, Lawrence P., Workman, Creg J., Vignali, Dario A. A. · 2019 · Immunology
Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis
Saige L. Pompura, Allon Wagner, Alexandra Kitz, Jacob M. Laperche, Nir Yosef, Margarita Dominguez‐Villar, David A. Hafler · 2020 · Journal of Clinical Investigation
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors
Kota Itahashi, Takuma Irie, Junichiro Yuda, Shogo Kumagai, Tokiyoshi Tanegashima, Yi-Tzu Lin, Sho Watanabe, Yasushi Goto, Jun Suzuki, Keiju Aokage et al. · 2022 · Science Immunology
A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma
Wei Sun, Fanqin Wei, Wei-Jin Li, Jia-Wei Wei, Hua Zhong, Yihui Wen, Wenbin Lei, Lin Chen, Hang Li, Hanqing Lin et al. · 2017 · British Journal of Cancer
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes
Laura Bonanno, Alberto Pavan, Maria Vittoria Dieci, Elisabetta Di Liso, Marco Schiavon, Giovanni Maria Comacchio, Ilaria Attili, Giulia Pasello, Fiorella Calabrese, Federico Rea et al. · 2018 · European Journal of Cancer
Gut microbiota-mediated immunomodulation in tumor
Liu, Xinyi, Chen, Yanjie, Zhang, Si, Dong, Ling · 2021 · Journal of Experimental & Clinical Cancer Research
Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer
Kai Chen, Yazhou Wang, Yuting Hou, Qi Wang, Di Long, Xinxin Liu, Xiaodong Tian, Yinmo Yang · 2022 · Cancer Letters
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
Yifei Zhu, Xinyan Li, Lei Wang, Xiwei Hong, Jie Yang · 2022 · Frontiers in Endocrinology
Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma
Aras Toker, Linh T. Nguyen, Simone C. Stone, S.Y. Cindy Yang, Sarah Rachel Katz, Patricia Ann Shaw, Blaise Alexander Clarke, Danny Ghazarian, Ayman Al‐Habeeb, Alexandra Maria Easson et al. · 2018 · Clinical Cancer Research
Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
Xuebing Yan, Liguo Liu, Hao Li, Huanlong Qin, Zhenliang Sun · 2017 · OncoTargets and Therapy
Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
Le Zhang, Xiaonan Xu, Xiulan Su · 2020 · Molecular Cancer
CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells
Myung‐Chul Kim, Nicholas C. Borcherding, Kawther Khalid Ahmed, Andrew P. Voigt, Ajaykumar Vishwakarma, Ryan H. Kolb, Paige Kluz, Gaurav Pandey, Umasankar De, Theodore T. Drashansky et al. · 2021 · Nature Communications
Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota
Han Yin, Zhuangzhuang Miao, Lu Wang, Beibei Su, Chaofan Liu, Yu Tong Jin, Bili Wu, Hu Han, Xianglin Yuan · 2022 · Aging
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
Naganari Ohkura, Yoshiaki Yasumizu, Yohko Kitagawa, Atsushi Tanaka, Yamami Nakamura, Daisuke Motooka, Shota Nakamura, Yukinori Okada, Shimon Sakaguchi · 2020 · Immunity
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Li, Yu, Zhang, Cangang, Jiang, Aimin, Lin, Anqi, Liu, Zaoqu, Cheng, Xiangshu, Wang, Wanting, Cheng, Quan, Zhang, Jian, Wei, Ting et al. · 2024 · Journal of Translational Medicine
Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice
Guoxin Huang, Imran Khan, Xiaoang Li, Lei Chen, Waikit Leong, Leung Tsun Ho, W.L. Wendy Hsiao · 2017 · Scientific Reports
Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
Imelda Seminerio, Géraldine Descamps, Sophie Dupont, Lisa G. De Marrez, Jean-Alexandre Laigle, Jerome Rene Lechien, Nadège Kindt, Fabrice Journé, Sven Saussez · 2019 · Cancers
Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe, Abigail E., Vignali, Dario A.A. · 2018 · Cancer Immunology Research
MondoA–Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment
Ying Lu, Yangyang Li, Q F Liu, Peng Du, Peng Du, Fangming Zhu, Yichao Han, Xisheng Liu, Xisheng Liu, Xiaoxia Wang et al. · 2021 · Gastroenterology
The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis
Yamei Zhao, Xiaoxu Ge, Jiawei He, Yi Cheng, Zhanhuai Wang, Jian Wang, Lifeng Sun · 2019 · World Journal of Surgical Oncology
Molecular mechanisms underlying Th1-like Treg generation and function
Alexandra Kitz, Margarita Dominguez‐Villar · 2017 · Cellular and Molecular Life Sciences
IL-17A-Producing Foxp3+Regulatory T Cells and Human Diseases
Min Kyung Jung, Jeong-Eun Kwak, Eui‐Cheol Shin · 2017 · Immune Network
IL-36γ signaling controls the induced regulatory T cell–Th9 cell balance via NFκB activation and STAT transcription factors
Akihito Harusato, Hirohito Abo, Vu L. Ngo, S.W. Yi, Kazunori Mitsutake, S. Osuka, Jacob E. Kohlmeier, Jiandong Li, Andrew T. Gewirtz, Asma Nusrat et al. · 2017 · Mucosal Immunology
T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment
Ziwen Zheng, Thomas Wieder, Bernhard Mauerer, Luisa Schäfer, Rebecca Kesselring, Heidi Braumüller · 2023 · International Journal of Molecular Sciences
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
Tanaka, Atsushi, Nishikawa, Hiroyoshi, Noguchi, Shinsuke, Sugiyama, Daisuke, Morikawa, Hiromasa, Takeuchi, Yoshiko, Ha, Danbee, Shigeta, Naoya, Kitawaki, Toshio, Maeda, Yuka et al. · 2020 · Journal of Experimental Medicine
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
Mariangela Lecciso, Darina Očadlíková, Sabina Sangaletti, Sara Trabanelli, Elena De Marchi, Elisa Orioli, Anna Pegoraro, Paola Portararo, Camilla Jandus, Andrea Bontadini et al. · 2017 · Frontiers in Immunology
USP21 prevents the generation of T-helper-1-like Treg cells
Yangyang Li, Yue Lu, Shuaiwei Wang, Zhijun Han, Fuxiang Zhu, Yingmeng Ni, Rui Liang, Yan Zhang, Qibin Leng, Gang Wei et al. · 2016 · Nature Communications
Immunoscore and its introduction in clinical practice
Jérôme Galon, Anastasia Lanzi · 2020 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting
Sonia Aristín Revilla, Onno Kranenburg, Paul James Coffer · 2022 · Frontiers in Immunology
Wnt–β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression
Jasmin Quandt, Stephen Arnovitz, Leila Haghi, Janine Woehlk, Azam Mohsin, Michael K. Okoreeh, Priya Mathur, Akinola Olumide Emmanuel, Abu Osman, Manisha Krishnan et al. · 2021 · Nature Immunology
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells
Y You, Yuelin Li, Ming‐Qing Li, M Lei, Mengyao Wu, Yuan Qu, Yan Yuan, Tong Chen, Hua Jiang · 2017 · Clinical & Experimental Immunology
A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
Richard D. Kim, Bence P. Kovari, Maria Martinez, Hao Xie, İbrahim Halil Şahin, Rutika Jitesh Mehta, Jonathan Strosberg, Iman Imanirad, Masoumeh Ghayouri, Youngchul Kim et al. · 2022 · European Journal of Cancer
Intratumoral FoxP3+Helios+ Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
Azharuddin Sajid Syed Khaja, Salman M. Toor, Haytham El Salhat, Bassam R. Ali, Eyad Elkord · 2017 · Frontiers in Immunology
Crosstalk between Macrophages, T Cells, and Iron Metabolism in Tumor Microenvironment
Lesang Shen, Yunxiang Zhou, Haifei He, Wuzhen Chen, Cameron Lenahan, Xiaoyi Li, Yongchuan Deng, Anwen Shao, Jian Huang · 2021 · Oxidative Medicine and Cellular Longevity
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
Alexey S. Revenko, Larissa S. Carnevalli, Charles Sinclair, Ben Johnson, Alison Peter, Molly A. Taylor, Lisa A. Hettrick, Melissa Chapman, Stéphanie Klein, Anisha Solanki et al. · 2022 · Journal for ImmunoTherapy of Cancer
The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases
Audrey Mohr, Mo Atif, ROBERT S. BALDERAS, Guy Gorochov, Makoto Miyara · 2019 · Clinical & Experimental Immunology
Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance
Sana Hibino, Shunsuke Chikuma, Taisuke Kondo, Minako Ito, Hiroko Nakatsukasa, Setsuko Omata‐Mise, Akihiko Yoshimura · 2018 · Cancer Research
Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells
Yixiang Han, Yuqing Dong, Qianqian Yang, Wanling Xu, Songfu Jiang, Zhijie Yu, Yu Kang, Shenghui Zhang · 2018 · Frontiers in Immunology
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response
Fabio Scirocchi, Simone Scagnoli, Andrea Botticelli, Alessandra Di Filippo, Chiara Napoletano, Ilaria Grazia Zizzari, Lidia Strigari, Federica Tomao, Enrico Cortesi, Aurelia Rughetti et al. · 2022 · EBioMedicine
Tumor‐infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
Yamamoto, Kei, Makino, Tomoki, Sato, Eiichi, Noma, Toshiki, Urakawa, Shinya, Takeoka, Tomohira, Yamashita, Kotaro, Saito, Takuro, Tanaka, Koji, Takahashi, Tsuyoshi et al. · 2020 · Cancer Science
Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance
Xin Zhang, Xiuting Liu, Wei Zhou, Qianming Du, Mengdi Yang, Yang Ding, Rong Hu · 2021 · Cellular and Molecular Gastroenterology and Hepatology
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development
Amy Li, Rebecca H. Herbst, David A. Canner, Jason M. Schenkel, Olivia C. Ghirardelli Smith, Jonathan Y. Kim, Michelle Hillman, Arjun J. Bhutkar, Michael S. Cuoco, C. Garrett Rappazzo et al. · 2019 · Cell Reports
Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response
Qianqian Zhang, Suhui Wu · 2023 · Frontiers in Immunology
Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers
Takashi Nomura, Tetsuya Honda, Kenji Kabashima · 2018 · International Immunology
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Marine Fidelle, Satoru Yonekura, Marion Picard, Alexandria P. Cogdill, Antoine Hollebecque, María Paula Roberti, Laurence Zitvogel · 2020 · Frontiers in Immunology
Mechanisms of Immunosuppression in Colorectal Cancer
Yang Zhang, Ashwani Rajput, Ning Yi Jin, Jing Wang · 2020 · Cancers
Regulatory T‐cell development in the tumor microenvironment
Kota Itahashi, Takuma Irie, Hiroyoshi Nishikawa · 2022 · European Journal of Immunology
An update on colorectal cancer microenvironment, epigenetic and immunotherapy
Ketao Jin, Chengcheng Ren, Yuyao Liu, Huanrong Lan, Zhen Wang · 2020 · International Immunopharmacology
Microbiota-driven antitumour immunity mediated by dendritic cell migration
Yi-Tzu Lin, Shota Fukuoka, Shohei Koyama, Daisuke Motooka, Dieter M. Tourlousse, Yuko Shigeno, Yuki Matsumoto, Hiroyuki Yamano, Kazutoshi Murotomi, Hideyuki Tamaki et al. · 2025 · Nature
Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
Yipeng He, Tianbao Song, Jinzhuo Ning, Zefeng Wang, Zhen Yin, Pengcheng Jiang, Qin Yuan, Weimin Yu, Cheng Fan · 2024 · Clinical and Translational Medicine
Targeting latency-associated peptide promotes antitumor immunity
Galina Gabriely, Andre Pires da Cunha, Rafael Machado Rezende, Brendan M. Kenyon, Asaf Madi, Tyler Vandeventer, Nathaniel P. Skillin, Stephen J. Rubino, Lucien P. Garo, Maria Antonietta Mazzola et al. · 2017 · Science Immunology
Relevance of Regulatory T Cells during Colorectal Cancer Development
Jonadab E. Olguín, Itzel Medina-Andrade, Tonathiu Rodríguez, Miriam Rodríguez‐Sosa, Luis Ignacio Terrazas · 2020 · Cancers
Friend or foe?
Tommaso Colangelo, Giovanna Polcaro, Livio Muccillo, Giovanna D'Agostino, Valeria Rosato, Pamela Ziccardi, Angelo Lupo, Gianluigi Mazzoccoli, Lina Sabatino, Vittorio Colantuoni · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control
Jinhai Deng, Teng Pan, Zaoqu Liu, Caitlin McCarthy, Jose Miguel Vicencio, Lulu Cao, Giovanna Alfano, Ali Abdulnabi Suwaidan, Mingzhu Yin, Richard Beatson et al. · 2023 · British Journal of Cancer
Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
Chi, Xiaowei, Yang, Peiwei, Zhang, Erhao, Gu, Jieyi, Xu, Hui, Li, Mengwei, Gao, Xinmei, Li, Xin, Zhang, Yinan, Xu, Hanmei et al. · 2019 · Cancer Medicine
Fusobacterium’s link to colorectal neoplasia sequenced: A systematic review and future insights
Hisham Hussan, Steven K. Clinton, Kristen Roberts, Michael T. Bailey · 2017 · World Journal of Gastroenterology
The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
José Manuel González-Navajas, Dengxia Denise Fan, Shuang Yang, Fengyuan Mandy Yang, Beatriz Lozano‐Ruiz, Liya Shen, Jong‐Dae Lee · 2021 · Frontiers in Immunology
Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression
Yu Wang, Jiazhou Li, Shingo Nakahata, Hidekatsu Iha · 2024 · International Journal of Molecular Sciences
Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
François Ghiringhelli, Jean-David Fumet · 2019 · Frontiers in Immunology
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
Yixiao Qin, Xiwang Zheng, Wei Gao, Binquan Wang, Yongyan Wu · 2021 · Molecular Therapy — Oncolytics
Gallic acid induces T-helper-1-like T reg cells and strengthens immune checkpoint blockade efficacy
Biaolong Deng, Biaolong Yang, Jieqiong Chen, Shuaiwei Wang, Weiqi Zhang, Yixian Guo, Yichao Han, Hecheng Li, Yongjun Dang, Yaqin Yuan et al. · 2022 · Journal for ImmunoTherapy of Cancer
Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation
Yosuke Togashi, Hiroyoshi Nishikawa · 2017 · Current topics in microbiology and immunology
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Chloé Laplagne, Marcin Domagala, Augustin Le Naour, Christophe Quémerais, Dimitri Hamel, Jean‐Jacques Fournié, Bettina C. Couderc, Corinne Bousquet, Audrey Ferrand, Mary Poupot · 2019 · International Journal of Molecular Sciences
Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models
Eriko Katsuta, Omar Maen Rashid, Kazuaki Takabe · 2020 · Human Cell
Computational immunogenomic approaches to predict response to cancer immunotherapies
Venkateswar Addala, Felicity Newell, John V. Pearson, Alec Redwood, Bruce W.S. Robinson, Jenette Creaney, Nicola Waddell · 2023 · Nature Reviews Clinical Oncology
Characteristics of Immune Response to Tumor‐Associated Antigens and Immune Cell Profile in Patients With Hepatocellular Carcinoma
Yuki Inada, Eishiro Mizukoshi, Takuya Seike, Toshikatsu Tamai, Noriho Iida, Masaaki Kitahara, Tatsuya Yamashita, Kuniaki Arai, Takeshi Terashima, Kazumi Fushimi et al. · 2018 · Hepatology
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review
René Novysedlák, Miray Guney, Majd Al Khouri, Robin Bartolini, Lily Koumbas Foley, Iva Benešová, Andrej Ozaniak, Vojtěch Novák, Štěpán Veselý, Pavel Pacas et al. · 2024 · Oncology
GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon
Mohammad Salem, Caroline H. Wallace, Maria Velegraki, Anqi Li, Ephraim Abrokwa Ansa-Addo, Alessandra Metelli, Hyunwoo Kwon, Brian Riesenberg, Bill Xingjun Wu, Yongliang Zhang et al. · 2019 · Cancer Research
The Tumor Microenvironment in Colorectal Cancer Therapy
Leire Pedrosa, Francis María Esposito, Timothy M. Thomson, Joan Maurel · 2019 · Cancers
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis
Tyler J. Goodwin, Leaf Huang · 2017 · Vaccine
Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC
Yixiu Wang, Yongfa Zhang, Longrong Wang, Ning Zhang, Weiqi Xu, Jiamin Zhou, Yiming Zhao, Weiping Zhu, Ti Zhang, Lu Wang · 2022 · Hepatology International
Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer
Martin J. Scurr, Tom Pembroke, Anja C. Bloom, David J. Roberts, Amanda Thomson, Kathryn Smart, Hayley M. Bridgeman, Richard Adams, Alison E. Brewster, Robert Jones et al. · 2017 · JAMA Oncology
The Potential Role of Exercise and Nutrition in Harnessing the Immune System to Improve Colorectal Cancer Survival
Mingyang Song, Andrew Tan Chan · 2018 · Gastroenterology
TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?
Astrid De Meulenaere, Tijl Vermassen, Sandrine Aspeslagh, Katrien Vandecasteele, Sylvie Rottey, Liesbeth Ferdinande · 2016 · Head and Neck Pathology
Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis
Masahito Watanabe, Kent Kanao, Susumu Suzuki, Hiroyuki Muramatsu, Singo Morinaga, Keishi Kajikawa, Ikuo Kobayashi, Genya Nishikawa, Yoshiharu Kato, Kenji Zennami et al. · 2019 · The Prostate
Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies
Randrian, Violaine, Evrard, Camille, Tougeron, David · 2021 · Cancers
New Insights into Regulatory T Cells: Exosome- and Non-Coding RNA-Mediated Regulation of Homeostasis and Resident Treg Cells
Peiyao Li, Changhong Liu, Zhibin Yu, Minghua Wu · 2016 · Frontiers in Immunology
Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer
Kazuya Masuda, Adam E. Kornberg, Jonathan D. Miller, Sijie Lin, Nathan Suek, Theo Botella, Kerim Secener, Alyssa Baccarella, Liang Cheng C, Matthew A. Ingham et al. · 2022 · JCI Insight
Powerful Anticolon Tumor Effect of Targeted Gene Immunotherapy Using Folate-Modified Nanoparticle Delivery of CCL19 To Activate the Immune System
Xiaoxiao Liu, Bilan Wang, Yanyan Li, Yuzhu Hu, Xiaoling Li, Ting Yu, Yan Ju, Tao Sun, Xiang Gao, Yuquan Wei · 2019 · ACS Central Science
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
Hassan Sadozai, Thomas Gruber, Robert E. Hunger, Mirjam Schenk · 2017 · Frontiers in Immunology
Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer
Francesca Ferrandino, Paola Grazioli, Diana Bellavia, Antonio Francesco Campese, Isabella Screpanti, María Pía Felli · 2018 · Frontiers in Immunology
The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response
Audrey Moatti, José Laurent Cohen · 2021 · Frontiers in Cell and Developmental Biology
Targeting tumor-infiltrating tregs for improved antitumor responses
Diyuan Qin, Yugu Zhang, Pei Shu, Yanna Lei, Xiaoyu Li, Yongsheng Wang · 2024 · Frontiers in Immunology
Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation
Tomonori Yaguchi, Yutaka Kawakami · 2016 · International Immunology
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status
Lee, Ji Ae, Yoo, Seung-Yeon, Oh, Hyeon Jeong, Jeong, Seorin, Cho, Nam-Yun, Kang, Gyeong Hoon, Kim, Jung Ho · 2021 · Cancer Immunology, Immunotherapy
Boosting regulatory T cell function for the treatment of autoimmune diseases – That’s only half the battle!
Janine Schlöder, Fatemeh Zare Shahneh, Franz-Joseph Schneider, Björn Wieschendorf · 2022 · Frontiers in Immunology
Regulatory T cells as a therapeutic approach for inflammatory bowel disease
Marcela Lauková, Arielle Glatman Zaretsky · 2022 · European Journal of Immunology
CD39+ regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
Filip Ahlmanner, Patrik Sundström, Paulina Akéus, Jenny Eklöf, Lars Börjesson, Bengt G. Gustavsson, Elinor Bexe Lindskog, Sukanya Raghavan, Marianne Quiding‐Järbrink · 2018 · Oncotarget
New strategies for cancer immunotherapy: targeting regulatory T cells
Francesca Finotello, Zlatko Trajanoski · 2017 · Genome Medicine